RAUWOLFIA SERPENTINA Drug Patent Profile
✉ Email this page to a colleague
When do Rauwolfia Serpentina patents expire, and what generic alternatives are available?
Rauwolfia Serpentina is a drug marketed by Bundy, Halsey, Impax Labs, Ivax Sub Teva Pharms, Purepac Pharm, Pvt Form, Solvay, Tablicaps, Valeant Pharm Intl, and Watson Labs. and is included in twelve NDAs.
The generic ingredient in RAUWOLFIA SERPENTINA is rauwolfia serpentina root. There are eight drug master file entries for this compound. Additional details are available on the rauwolfia serpentina root profile page.
Summary for RAUWOLFIA SERPENTINA
US Patents: | 0 |
Applicants: | 10 |
NDAs: | 12 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | RAUWOLFIA SERPENTINA at DailyMed |
Recent Clinical Trials for RAUWOLFIA SERPENTINA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 |